We reviewed our experience with isolated lung transplantation at Loyola University Medical Center, Maywood, Ill. From April 1990 through June 1992, 33 lung transplantations for end-stage pulmonary disease were performed (30 single lung, three bilateral single lung). Recipient diagnoses include chronic obstructive pulmonary disease, α1-antiprotease deficiency, pulmonary fibrosis, primary pulmonary hypertension, Eisenmenger's syndrome, sarcoidosis, cystic fibrosis, bronchiectasis, and bronchiolitis obliterans.
For patients who underwent transplantation for end-stage obstructive airway disease, we retrospectively reviewed functional indexes before and after transplantation. In addition, the overall survival rate was determined.
Successful transplantation resulted in a marked improvement in functional capacity. Singlelung transplantation for end-stage obstructive airway disease resulted in a threefold improvement in the 1-second forced expiratory volume, from 0.49 to 1.64 L. The actual survival for all isolated lung transplant recipients (including both single-lung and bilateral single-lung procedures) was 73%, with a 15% 30-day mortality.
Isolated lung transplantation can significantly improve functional capacity as well as the quality of life in patients with end-stage lung disease.(Arch Intern Med. 1993;153:2769-2773)
Doud JR, McCabe MM, Montoya A, Garrity ER. The Loyola University Lung Transplant Experience. Arch Intern Med. 1993;153(24):2769–2773. doi:10.1001/archinte.1993.00410240077009
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: